Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Net Income: 2022-2025

Historic Net Income for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to -$892,300.

  • Addex Therapeutics' Net Income rose 65.69% to -$892,300 in Q2 2025 from the same period last year, while for Jun 2025 it was -$1.6 million, marking a year-over-year increase of 79.94%. This contributed to the annual value of $13.6 million for FY2024, which is 251.63% up from last year.
  • Per Addex Therapeutics' latest filing, its Net Income stood at -$892,300 for Q2 2025, which was down 36.64% from -$653,016 recorded in Q1 2025.
  • In the past 5 years, Addex Therapeutics' Net Income registered a high of $6.6 million during Q4 2022, and its lowest value of -$7.5 million during Q2 2022.
  • Its 3-year average for Net Income is -$1.2 million, with a median of -$867,290 in 2024.
  • As far as peak fluctuations go, Addex Therapeutics' Net Income plummeted by 133.51% in 2023, and later skyrocketed by 99.87% in 2024.
  • Quarterly analysis of 4 years shows Addex Therapeutics' Net Income stood at $6.6 million in 2022, then crashed by 133.51% to -$2.2 million in 2023, then spiked by 99.18% to -$18,156 in 2024, then skyrocketed by 65.69% to -$892,300 in 2025.
  • Its Net Income was -$892,300 in Q2 2025, compared to -$653,016 in Q1 2025 and -$18,156 in Q4 2024.